Noise level goes up on AIDS vaccine

Politics & Policy

ROCKVILLE, Md. - Scientific controversy over the risks and benefits of a live attenuated AIDS vaccine came into public view last week, with top NIH officials accusing AIDS physicians who are pushing for human trials of a vaccine of minimizing the dangers and significantly underestimating the amount of work needed before a Phase I trial can begin.

In return, vaccine proponents accused leading U.S. AIDS researchers of delaying development of what they say is the only type of vaccine that has shown a high degree of efficacy.

Read the full 907 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE